UMC
0256 S0.320
0.320
0.000 (0.0%)| High | 0.330 |
| Low | 0.315 |
| Open | 0.315 |
| Volume | 96,200 |
| Volume (B/S) | 29,900 / 9,900 |
| Price Bid/Ask | 0.315 / 0.320 |
| 52w | 0.280 - 0.475 |
| ROE | 9.67 |
| P/E | 14.63 |
| EPS | 2.19 |
| DPS | 0.30 |
| DY | 0.94% |
| NTA | 0.2265 |
| P/B | 1.41 |
| RPS | 13.98 |
| PSR | 2.29 |
| Market Cap | 119.7M |
| Shares (mil) | 373.91 |
| RQoQ RYoY |
| CAGR |
3Y
6370%
TTM
286%
5Y
-5282%
TTM
3470%
|
|
| RSI(14) | Neutral 53.7 |
| Stochastic(14) | Neutral 54.5 |
| Stochastic RSI(14) | Neutral 51.6 |
| Average Volume (3M) | 122,600 |
| Relative Volume | 1.4 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jul, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 Jan 2026 | 31 Jul 2026 | First Interim Dividend | 29 Jan 2026 | 10 Feb 2026 | 0.0030 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
UMediC’s high-margin medical products to fuel growth
PETALING JAYA: UMediC Group Bhd (UMC) is carving out a niche in the global medical device market by shifting towards higher-value proprietary products, with MBSB Research saying limited global competition is expected to underpin its next phase of growth.TheStar -
Brokers Digest: Local Equities - Kee Ming Group Bhd, ITMAX System Bhd, UMediC Group Bhd, VS Industry Bhd
This article first appeared in Capital, The Edge Malaysia Weekly on June 29, 2026 - July 5, 2026 Kee Ming Group Bhd Target price: RM2.00 OUTPERFORM KENANGA RESEARCH (JUNE 25): Kee Ming Group Bhd (KL:KEEMING) has accepted a letter of award from a wholly-owned ...TheEdge -
Rising demand to fuel UMedic Group’s expansion
UMedic Group Bhd expects growth momentum to be supported by expanding manufacturing capacity, a rising order book and new product initiatives over the coming years.TheStar -
Mixed outlook for UMediC amid earnings upgrade
Hong Leong Investment Bank (HLIB) Research remains cautious on UMediC Group Bhd despite raising its earnings forecasts, while Phillip Capital Research continues to see value in the healthcare product maker's longer-term growth prospects, underpinned by expansion plans and a stronger distribution business.TheStar -
【行家论股】税率利好提振盈利 UMediC末季复苏可期
UMediC集团(UMC,0256,创业板)近期公布2026财政年第3季业绩表现略优于丰隆投行的预期...Nanyang
Recent Announcements
-
Quarterly rpt on consolidated results for the financial period ended 30/04/2026
-
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Commencement of Members' Voluntary Winding Up of Subsidiary -
Quarterly rpt on consolidated results for the financial period ended 31/01/2026
-
OTHERS
UMEDIC GROUP BERHAD ("UMC" OR "COMPANY") PROPOSED LEASE OF LAND -
UMC - Notice of Book Closure